Le Lézard
Classified in: Health, Business
Subjects: PDT, LIC, PET, CXP

PetWellClinic Builds Off Momentum with Q3 Growth, Signaling Increase in Demand for Pet Care


Emerging Veterinary Pet-Wellness Franchise Welcomes Four New Locations, Signs Multi-Unit Development Deal in Q3

KNOXVILLE, Tenn., Nov. 6, 2023 /PRNewswire/ -- PetWellClinic, one of America's fastest-growing veterinary pet-wellness franchise brands, wrapped up the third quarter with vast plans for growth following a finalized six-unit agreement in Florida. The deal to introduce the brand to Tampa, Florida comes at the hands of entrepreneurs who had previously invested in franchise locations in New Jersey.

"We're honored that our franchise owners are so confident in our brand that soon after their initial investment, they're eager to go back and purchase secondary territories," said Dr. Sam Meisler, DVM, Founder and CEO of PetWellClinic. "Demand is growing for convenient, easily accessible and affordable pet care in Florida, as is evident by the success our clinics have seen across the state. The addition of these locations to Tampa will provide a meaningful service for owners to take better care of their family pets."

PetWellClinic broadened its footprint in Q3 with the addition of four new clinics, opening in Pittsburgh, PA, Columbia, MD, and Mandeville, LA. Also included in PetWellClinic's plans for growth are at least two new clinics scheduled to open before the end of the year, with several more anticipated to quickly follow at the start of 2024. As pet owners juggle high patient costs and lengthy wait times often associated with traditional veterinary practices, PetWellClinic stands out with an alternative solution of walk-in vet visits for preventative care, such as general check-ups, vaccinations, and treatments of minor ailments and chronic conditions.

For more information about PetWellClinic franchise opportunities, please visit www.petwellfranchise.com. PetWellClinic has partnered with Oakscale, to lead franchise development efforts for the brand. For more information about Oakscale, please visit www.oakscale.com or contact Ryan Durishin at [email protected]

ABOUT PETWELLCLINIC 
PetWellClinic is a walk-in veterinary clinic, providing excellent preventative, wellness and sick care for dogs and cats on an on-demand basis. There is no need for an appointment because PetWellClinic's technology, design, and operational systems provide customers with a modern-day experience in an antiquated industry. PetWellClinic recently began franchising after the success of its company-owned operations in Knoxville, Tennessee, and currently has over 100 units in development. 

SOURCE PetWellClinic


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: